WHO GIVES ENDORSEMENT TO CANADIAN COMPANY'S COMBINATION HIV/AIDS DRUG

The World Health Organization gave its approval to Apo-triAvir, a generic HIV/AIDS medication made by the Toronto-based drug company Apotex, a "critical step" in allowing the drug to be exported to developing countries, the Toronto Star reports. Apo-triAvir contains nevirapine and two other drugs in a single-pill format. Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=49634&nfid=rssfeeds)